Stay updated on ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.

Latest updates to the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page
- Check3 days agoChange DetectedRemoved references to the condition Multiple Myeloma and related topics, including MedlinePlus Genetics, from the study page. This alters the page's disease-related keywords and related-topic associations.SummaryDifference0.2%

- Check10 days agoChange DetectedThe page now includes new related topics: 'Multiple myeloma' and a link/reference to 'MedlinePlus Genetics', expanding the disease focus context and providing an accessible genetics resource.SummaryDifference0.2%

- Check17 days agoChange DetectedThe page’s revision/version indicator has been updated from v3.5.2 to v3.5.3, reflecting a minor site update rather than a change to the clinical trial details.SummaryDifference0.1%

- Check24 days agoChange DetectedAdded Revision: v3.5.2. Removed references to Multiple Myeloma and related topics (MedlinePlus Genetics) and noted Revision: v3.5.0.SummaryDifference0.2%

- Check53 days agoChange DetectedAdded 'Multiple myeloma' as a related topic and linked 'MedlinePlus Genetics'. The site revision was updated from 3.4.3 to 3.5.0.SummaryDifference0.2%

- Check60 days agoChange DetectedThe page now displays a new revision label: v3.4.3, replacing the previous v3.4.2.SummaryDifference0.1%

Stay in the know with updates to ASCT With Nivolumab in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ASCT With Nivolumab in Multiple Myeloma Clinical Trial page.